• KOL
    • KOLs Community
    • Cluster
    • Cluster Headache
    • Gisela Marie Terwindt
    • Gisela Marie Terwindt

      Gisela Marie Terwindt

      Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands | Department of Neurology (G.M.T., M.J.H.W.), Leiden University Medical Center, Leiden, the ...

       

       

      KOL Resume for Gisela Marie Terwindt

      Year
      2022

      Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands

      2021

      Department of Neurology, Leiden University Medical Center, Leiden, Netherlands

      Leiden University Medical Center: Leids Universitair Medisch Centrum

      2020

      From the Department of Neurology (E.A.K., S.V., I.R., E.S.v.E., M.J.H.W., G.M.T.), Leiden University Medical Center, the Netherlands.

      Analytic and Translational Genetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA

      Leiden University Medical Centre, Department of Neurology, PO Box 9600, 2300 RC Leiden, The Netherlands

      2019

      Department of Neurology.

      Leiden University Medical Center, Leiden, the Netherlands.

      2018

      Wilhelmina Children’s Hospital Birth Center (G.A.Z., B.B.v.R., A.F.) Department of Reproductive Medicine and Gynaecology (B.C.J.M.G.) Julius Center for Health Sciences and Primary Care (Y.v.d.G.) Department of Vascular Medicine (F.L.V.) Department of Radiology (B.K.V.), University Medical Center Utrecht, Netherlands Department of Obstetrics and Gynaecology (L.B., E.A.P.S.) Department of Cardiology (E.B., R.P.J.B.) Department of Radiology (R.P.J.B.) Department of Internal Medicine (J.E.R.v.L.), Erasmus Medical Center, Rotterdam, Netherlands Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands (G.J.M.d.G.) Department of Cardiology, Radboud University Medical Center, Nijmegen, Netherlands (A.H.E.M.M.) Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.).

      From the Departments of Neurology (N.P., J.H., A.H.S., A.S., M.D.F., A.M.J.M.v.d.M., G.M.T.) and Human Genetics (L.S.V., S.C.K., B.d.V., A.M.J.M.v.d.M.), Leiden University Medical Centre; and Department of Neurology (J.H.), Alrijne Hospital, Leiderdorp, the Netherlands.

      Department of Neurology, LUMC, Leiden, The Netherlands

      2017

      Department of Neurology, Leiden University Medical Center, The Netherlands

      2016

      From the Departments of Neurology (E.S.v.E., J.H., G.M.T., M.J.H.W.), Radiology (J.v.d.G., M.A.v.B.), and Clinical Epidemiology (A.A.), Leiden University Medical Center; Department of Neurology (J.H.), Alrijne Hospital; Department of Neurology and Neurosurgery (A.A.), Brain Center Rudolf Magnus and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands; Hemorrhagic Stroke Research Program (M.E.G., A.V., K.M.S., A.M.A., S.M.G.), Department of Neurology, Massachusetts General Hospital Stroke Research Center; and Division of Neurocritical Care and Emergency Neurology (J.R.), Massachusetts General Hospital, Harvard Medical School, Boston.

      Department of Neurology, Leiden University Medical Centre, the Netherlands

      2015

      Dept. Neurology, Leiden University Medical Centre, Leiden, The Netherlands

      Departments of Neurology and

      Author affiliations are provided at the end of the article.

      2014

      From the Division of Pharmacology and Vascular Medicine, Department of Internal Medicine (K.I., A.H.J.D., I.M.G., A.H.v.d.M., A.M.V.D.B.), and Departments of Gynaecology (W.v.D.), Psychiatry (S.A.K.), and Biostatistics (E.M.E.H.L.), Erasmus MC, Rotterdam; and Department of Neurology (W.P.J.v.O., G.M.T., M.D.F.), Leiden University Medical Center, the Netherlands.

      Department of Neurology, Leiden University Medical Center (LUMC), the Netherlands

      2013

      Leiden University Medical Center Department of Neurology Leiden The Netherlands

      2012

      Departments of Radiology (Drs Palm-Meinders, Konishi, van Buchem, and Kruit and Ms Moonen), Division of Image Processing (Mr van Lew), Neurology (Drs Koppen, Terwindt, and Ferrari), and Neuropsychology (Dr Middelkoop), Leiden University Medical Center, the Netherlands

      2011

      Leiden University Medical Center, The Netherlands.

      2010

      From the Departments of Neurology (A.H.S., A.M.J.M.v.d.M., M.D.F., G.M.T.) and Human Genetics (B.d.V., K.R.J.V., P.H., R.R.F., A.M.J.M.v.d.M.), Leiden University Medical Centre, Leiden; and Department of Epidemiology (A.C.J.W.J.) and Genetic Epidemiology Unit, Departments of Epidemiology and Clinical Genetics (Y.S.A., B.A.O., C.M.v.D.), Erasmus University Medical Centre, the Netherlands.

      2009

      Department of Neurology, Leiden University Medical Centre, Leiden

      2008

      Department of Neurology and Clinical Genetic, Erasmus Medical Centre, Leiden, The Netherlands

      2007

      Department of Neurology, Leiden University Medical Centre, 2300 RC, Leiden, The Netherlands

      2006

      Department Neurology, Leiden University Medical Centre Leiden, Leiden

      2005

      From the Laboratory of Epidemiology, Demography, and Biometry (Drs. Scher and Launer), National Institute on Aging, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Terwindt and Ferrari), Leiden University Medical Center, Leiden, The Netherlands; Center for Prevention and Health Services Research (Drs. Picavet, Verschuren, and Launer), National Institute of Public Health and the Environment, Bilthoven, The Netherlands.

      Neurology, Leiden University Medical Center, Leiden, the Netherlands

      2004

      From the Department of Neurology and Clinical Neurophysiology, Leiden University Medical Center, The Netherlands.

      Department of Neurology (K5Q), Leiden University Medical Centre, PO Box 9600, 2300, RC Leiden, The Netherlands

      2003

      Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands, e-mail: Tel.: +31-71-5262587, Fax: +31-71-5248253, , NL

      2002

      Department of Neurology, K5Q, Leiden University Medical Centre, P. O. Box 9600, 2300 RC Leiden, The Netherlands. NL

      2001

      From the Department of Neurology (Drs. Terwindt, Ophoff, Haan, and Ferrari, and M.N. Vergouwe) and MGC–Department of Human and Clinical Genetics (Drs. Ophoff, Frants, and Sandkuijl and R. van Eijk and M.N. Vergouwe), Leiden University Medical Centre; Rijnland Hospital (Dr. Haan), Leiderdorp; and MGC–Department of Clinical Genetics (Dr. Sandkuijl), Erasmus University Rotterdam, the Netherlands.

      2000

      Department of Neurology, Leiden University Medical Centre, The Netherlands.

      1999

      From the Department of Chronic Disease Epidemiology (Dr. Launer), National Institute of Public Health and the Environment, Bilthoven; and the Department of Neurology (Drs. Terwindt and Ferrari), Leiden University Medical Centre, the Netherlands.

      Departments of Neurology, Leiden University Medical Centre

      1998

      Department of Human Genetics, Sylvius Laboratory, Leiden University Medical Center, Wassenaarseweg 72, 2333 RA Leiden, The Netherlands, and

       

       

      Gisela Marie Terwindt: Influence Statistics

      Sample of concepts for which Gisela Marie Terwindt is among the top experts in the world.
      Concept World rank
      midadult onset #1
      silico training #1
      region migraine #1
      sumatriptan dbf #1
      870 migraine patients #1
      common forms migraine #1
      trigeminovascular effects #1
      migraine subtype #1
      migraine treatment unmet #1
      women triggers #1
      migraine stroke patients #1
      rvcls #1
      familial migraine cases #1
      erenumabtreated patients #1
      cadasil midadult onset #1
      common migraine subtypes #1
      test dna variants #1
      stronger migraine #1
      monoclonal new drugs #1
      dbf young adult #1
      aura phenotype polymorphism #1
      mmd mamd #1
      age 18–45 years #1
      ehf panel #1
      notch3 severity #1
      chronic headache chronic #1
      phosphoproteins retinal #1
      triptans women #1
      notch3 mutations diagnosis #1
      5 dna exonuclease #1
      define effectiveness #1
      69 bright light #1
      notch3 exon skipping #1
      patients hormonal contraceptives #1
      women bright light #1
      metabolites migraine #1
      secondedition criteria #1
      fhm locus #1
      attention genetic relationship #1
      notch3 protein majority #1
      migraine screener stroke #1
      migraine preeclamptic women #1
      wml migraine #1
      effectiveness preventive treatment #1
      leukoencephalopathy systemic #1
      depression migraine #1
      rvcls patients #1
      mild notch3 staining #1
      migraine prevention monoclonal #1
      notch3 severity illness #1

       

      Prominent publications by Gisela Marie Terwindt

      KOL-Index: 17552

      CONTEXT: Clinical series have suggested an increased prevalence of cerebral infarction and white matter lesions (WMLs) in migraine patients. It is not known whether these lesions are prevalent in the general migraine population.

      OBJECTIVES: To compare the prevalence of brain infarcts and WMLs in migraine cases and controls from the general population and to identify migraine characteristics associated with these lesions.

      DESIGN: Cross-sectional, prevalence study of population-based ...

      Known for Brain Lesions | Migraine Controls | Aura Patients | Attack Frequency | Increased Prevalence
      KOL-Index: 14547

      BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-related peptide (eptinezumab, fremanezumab, and galcanezumab). The aim of this document by the European Headache Federation (EHF) is to provide an evidence-based and expert-based guideline on ...

      Known for Monoclonal Antibodies | Calcitonin Gene | European Headache Federation | Migraine Prevention | Erenumab Fremanezumab
      KOL-Index: 13600

      OBJECTIVE: To assess the involvement of the 19p13 familial hemiplegic migraine (FHM) locus in migraine with and without aura.

      BACKGROUND: Migraine with and without aura are likely to be polygenetic multifactorial disorders. FHM is a rare dominantly inherited type of migraine with aura. In about 50% of families, FHM is caused by mutations in the P/Q-type calcium channel alpha(1A)-subunit (CACNA1A) gene on chromosome 19p13. The CACNA1A gene is thus a good candidate gene for "nonhemiplegic" ...

      Known for Migraine Aura | Cacna1a Gene | Lod Score | 19p13 Locus | Calcium Channels
      KOL-Index: 13222

      Trivial head trauma may be complicated by severe, sometimes even fatal, cerebral edema and coma occurring after a lucid interval ("delayed cerebral edema"). Attacks of familial hemiplegic migraine (FHM) can be triggered by minor head trauma and are sometimes accompanied by coma. Mutations in the CACNA1A calcium channel subunit gene on chromosome 19 are associated with a wide spectrum of mutation-specific episodic and chronic neurological disorders, including FHM with or without coma. We ...

      Known for Minor Head Trauma | Delayed Cerebral Edema | Calcium Channel | Cacna1a Gene | Fatal Coma
      KOL-Index: 12786

      BACKGROUND: Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of migraine that has improved pharmacokinetic properties compared with sumatriptan succinate.

      OBJECTIVE: To assess the efficacy and tolerability of 10-, 20-, and 40-mg doses of oral rizatriptan vs a 100-mg dose of oral sumatriptan succinate and placebo for the acute treatment of migraine.

      DESIGN: Randomized, double-blind, parallel-group, placebo-controlled, ...

      Known for Acute Treatment | Rizatriptan Sumatriptan | Patients Migraine | 2 Hours | Headache Relief
      KOL-Index: 11883

      BACKGROUND: Familial (FHM) and sporadic (SHM) hemiplegic migraine are severe subtypes of migraine associated with transient hemiparesis. For FHM, three genes have been identified encoding subunits of a calcium channel (CACNA1A), a sodium-potassium pump (ATP1A2), and a sodium channel (SCN1A). Their role in SHM is unknown. Establishing a genetic basis for SHM may further the understanding of its pathophysiology and relationship with common types of migraine. It will also facilitate the ...

      Known for Fhm Genes | Shm Patients | Transient Hemiparesis | Sodium Channel | Atp1a2 Mutations
      KOL-Index: 11805

      CONTEXT: A previous cross-sectional study showed an association of migraine with a higher prevalence of magnetic resonance imaging (MRI)-measured ischemic lesions in the brain.

      OBJECTIVE: To determine whether women or men with migraine (with and without aura) have a higher incidence of brain lesions 9 years after initial MRI, whether migraine frequency was associated with progression of brain lesions, and whether progression of brain lesions was associated with cognitive decline.

      DESIGN, ...

      Known for Migraine Progression | Brain Lesions | White Matter | Higher Prevalence | Resonance Imaging
      KOL-Index: 11631

      BACKGROUND: Loss of cortical grey matter is a diagnostic marker of many neurodegenerative diseases, and is a key mediator of cognitive impairment. We postulated that cerebral amyloid angiopathy (CAA), characterised by cortical vascular amyloid deposits, is associated with cortical tissue loss independent of parenchymal Alzheimer's disease pathology. We tested this hypothesis in patients with hereditary cerebral haemorrhage with amyloidosis-Dutch type (HCHWA-D), a monogenetic disease with ...

      Known for Cortical Atrophy | Cerebral Amyloid | Caa Patients | Vascular Dysfunction | Alzheimers Disease
      KOL-Index: 11608

      OBJECTIVE: To investigate the co-occurrence of migraine and depression and assess whether shared genetic factors may underlie both diseases.

      METHODS: Subjects were 2,652 participants of the Erasmus Rucphen Family genetic isolate study. Migraine was diagnosed using a validated 3-stage screening method that included a telephone interview. Symptoms of depression were assessed using the Center for Epidemiologic Studies Depression scale and the depression subscale of the Hospital Anxiety and ...

      Known for Migraine Depression | Genetic Factors | Bidirectional Association | Depressive Disorder | Surveys Questionnaires
      KOL-Index: 11167

      BACKGROUND: Familial hemiplegic migraine (FHM) is a rare autosomal dominant subtype of migraine with aura. Missense mutations in the chromosome 19 CACNA1A calcium channel gene have been found in approximately half of the families. The T666M mutation, replacing a threonine by a methionine at residue number 666, is the most frequent mutation, reported in 14 independent FHM families; other mutations have so far been described in only 1 or 2 families each. The clinical features of T666M ...

      Known for Familial Hemiplegic Migraine | Cacna1a Gene | Fhm Families | Phenotypic Spectrum | T666m Mutation
      KOL-Index: 10896

      Migraine headache is widely believed to be associated with cerebral or meningeal vasodilatation. Human evidence for this hypothesis is lacking. 3 Tesla magnetic resonance angiography (3T MRA) allows for repetitive, non-invasive, sensitive assessment of intracranial vasodilatation and blood flow. Nitroglycerine (NTG) can faithfully induce migraine attacks facilitating pathophysiological studies in migraine. Migraineurs (n = 32) randomly received NTG (IV 0.5 microg/kg/min for 20 min; n = ...

      Known for Migraine Headache | Magnetic Resonance | Blood Flow | Infusion Ntg | Middle Cerebral
      KOL-Index: 10592

      Familial hemiplegic migraine (FHM) is a rare, severe, autosomal dominant subtype of migraine with aura. Up to 75% of FHM families have a mutation in the P/Q-type calcium channel Ca(v)2.1 subunit CACNA1A gene on chromosome 19p13. Some CACNA1A mutations also may cause epilepsy. Here, we describe novel missense mutations in the ATP1A2 Na(+),K(+)-ATPase pump gene on chromosome 1q23 in two families with FHM. The M731T mutation was found in a family with pure FHM. The R689Q mutation was ...

      Known for Benign Familial | Gene Atp1a2 | Aura Mutation | Infantile Convulsions | Migraine Fhm
      KOL-Index: 10370

      BACKGROUND: Migraine, particularly with aura, is a risk factor for early-onset ischemic stroke. The underlying mechanisms are unknown, but may in part be due to migraineurs having an increased risk profile for cardiovascular disease. In this study, the authors compare the cardiovascular risk profile of adult migraineurs to that of nonmigraineurs.

      METHODS: Participants (n = 5,755, 48% men, age 20 to 65 years) are from the Genetic Epidemiology of Migraine (GEM) study, a population-based ...

      Known for Cardiovascular Risk | Aura Migraine | Myocardial Infarction | Oral Contraceptive | Underlying Mechanisms
      KOL-Index: 10055

      Familial hemiplegic migraine (FHM) is an autosomal dominant subtype of migraine with aura, with half of the families being assigned to chromosome 19p13. We identified missense mutations in a brain-specific calcium channel alpha1A-subunit (CACNA1A) gene on 19p13 segregating with FHM and truncating mutations in families with episodic ataxia type 2 (EA-2). Expansions of an intragenic CAG repeat have been shown in autosomal dominant cerebellar ataxia (SCA6). Hence, FHM, EA-2, and SCA6 are ...

      Known for Familial Hemiplegic Migraine | Calcium Channel | Cerebellar Ataxia | Patients Fhm | Variable Clinical Expression

      Key People For Cluster Headache

      Top KOLs in the world
      #1
      Peter James Goadsby
      cluster headache chronic migraine acute treatment
      #2
      Arne May
      cluster headache migraine patients chronic pain
      #3
      Gennaro Bussone
      cluster headache chronic migraine medication overuse
      #4
      Anish Bahra
      cluster headache brain cancer hemicrania continua
      #5
      Karl Ekbom
      cluster headache basilar artery lifetime prevalence
      #6
      Gian Camillo Manzoni
      cluster headache chronic migraine psychiatric comorbidity

      Gisela Marie Terwindt:Expert Impact

      Concepts for whichGisela Marie Terwindthas direct influence:Cluster headache,  Familial hemiplegic migraine,  Hemiplegic migraine,  Migraine aura,  Migraine patients,  Aura migraine,  Retinal vasculopathy,  Amyloid angiopathy.

      Gisela Marie Terwindt:KOL impact

      Concepts related to the work of other authors for whichfor which Gisela Marie Terwindt has influence:Migraine aura,  Cluster headache,  Psychiatric disorders,  Bipolar disorder,  Ischemic stroke,  Calcium channels,  Cortical spreading depression.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands | Department of Neurology (G.M.T., M.J.H.W.), Leiden University Medical Center, Leiden, the Netherlands. | Department of Neurology, Leiden University Medical Center, L

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.